Literature DB >> 21160810

Significance of biological resource collection and tumor tissue bank creation.

Ying-Yan Yu1, Zheng-Gang Zhu.   

Abstract

Progress in the molecular oncology of gastrointestinal carcinomas depends on high quality cancer tissues for research. Recent acceleration on new technological platforms as well as the "omics" revolution increases the demands on tissues and peripheral blood for research at the DNA, mRNA and protein levels. Tissue bank creation emerges as a priority. Tumor tissue banks are facilities that are organized to collect, store and distribute samples of tumor and normal tissue for further use in basic and translational cancer research. The samples are generally obtained immediately after excision, prior to fixation, to ensure optimal preservation of proteins and nucleic acids. It is possible for surgeons or pathologists to collect fresh tissue prospectively during their routine dissection procedures. Most tissue banks are "project-driven" tumor banks, which are specialized collections of tumor samples on which their research is based. Systematic collection of all available tumor tissue is much rarer. High quality tissue banks need the collaboration of clinicians and basic scientists, but also the informed consent of patients and ethical approval. Through the standard operation procedure, snap frozen fresh tissue collection, storage and quality control for cryopreserved tissues are the pivotal factors on tissue bank construction and maintaining. The purpose of the tissue bank creation is enhancing the quality and speed on both the basic and translational research on gastrointestinal cancer. The quality assurance and quality control are handled based on reviewing HE staining slides or touch imprint cytology by pathologists.

Entities:  

Keywords:  Bioresource; Cryopreservation; Quality control; Tissue bank

Year:  2010        PMID: 21160810      PMCID: PMC2999151          DOI: 10.4251/wjgo.v2.i1.5

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  18 in total

1.  Genebanks: a comparison of eight proposed international genetic databases.

Authors:  Melissa A Austin; Sarah Harding; Courtney McElroy
Journal:  Community Genet       Date:  2003

Review 2.  Frozen tissue biobanks. Tissue handling, cryopreservation, extraction, and use for proteomic analysis.

Authors:  Christer Ericsson; Bo Franzén; Monica Nistér
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

3.  Standard operating procedure for the collection of fresh frozen tissue samples.

Authors:  S R Mager; M H A Oomen; M M Morente; C Ratcliffe; K Knox; D J Kerr; F Pezzella; P H J Riegman
Journal:  Eur J Cancer       Date:  2007-02-27       Impact factor: 9.162

4.  The use of archival frozen tumor tissue imprint specimens for fluorescence in situ hybridization.

Authors:  D J Demetrick
Journal:  Mod Pathol       Date:  1996-02       Impact factor: 7.842

5.  Biorepository standards and protocols for collecting, processing, and storing human tissues.

Authors:  Dean Troyer
Journal:  Methods Mol Biol       Date:  2008

Review 6.  Initiating tumor banking for translational research: MD Anderson and Liverpool experience.

Authors:  A Mishra; A Pandey; R Shaw
Journal:  Indian J Cancer       Date:  2007 Jan-Mar       Impact factor: 1.224

7.  Attitudes and perceptions of patients towards methods of establishing a DNA biobank.

Authors:  Jill M Pulley; Margaret M Brace; Gordon R Bernard; Dan R Masys
Journal:  Cell Tissue Bank       Date:  2007-10-25       Impact factor: 1.522

8.  Informatics-guided procurement of patient samples for biomarker discovery projects in cancer research.

Authors:  K Stephen Suh; Yvonne K Remache; Jalpa S Patel; Steve H Chen; Russell Haystrand; Peggy Ford; Anadil M Shaikh; Jian Wang; Andre H Goy
Journal:  Cell Tissue Bank       Date:  2008-11-19       Impact factor: 1.522

Review 9.  Tumour banks: well-guarded treasures in the interest of patients.

Authors:  J Wolter Oosterhuis; Jan Willem Coebergh; Evert-Ben van Veen
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

10.  Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer.

Authors:  Rosa F Hwang; Huamin Wang; Axbal Lara; Henry Gomez; Tracy Chang; Nicole Sieffert; Younghee Moon; Sabina Ram; Stuart Zimmerman; Jeffrey H Lee; Peter W T Pisters; Eric P Tamm; Jason B Fleming; James L Abbruzzese; Douglas B Evans
Journal:  Ann Surg Oncol       Date:  2008-02-07       Impact factor: 5.344

View more
  5 in total

Review 1.  Translating metastasis-related biomarkers to the clinic--progress and pitfalls.

Authors:  François-Clément Bidard; Jean-Yves Pierga; Jean-Charles Soria; Jean Paul Thiery
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

2.  Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma.

Authors:  Marius I Ilie; Véronique Hofman; Christelle Bonnetaud; Katia Havet; Virginie Lespinet-Fabre; Céline Coëlle; Virginie Gavric-Tanga; Nicolas Vénissac; Jerôme Mouroux; Paul Hofman
Journal:  Virchows Arch       Date:  2010-08-28       Impact factor: 4.064

3.  Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancer.

Authors:  Hua-Jun Chen; Jin-Ji Yang; Liang-Yi Fang; Min-Min Huang; Hong-Hong Yan; Xu-Chao Zhang; Chong-Rui Xu; Yi-Long Wu
Journal:  Thorac Cancer       Date:  2014-03-03       Impact factor: 3.500

4.  Quantifying the use of bioresources for promoting their sharing in scientific research.

Authors:  Laurence Mabile; Raymond Dalgleish; Gudmundur A Thorisson; Mylène Deschênes; Robert Hewitt; Jane Carpenter; Elena Bravo; Mirella Filocamo; Pierre Antoine Gourraud; Jennifer R Harris; Paul Hofman; Francine Kauffmann; Maria Angeles Muñoz-Fernàndez; Markus Pasterk; Anne Cambon-Thomsen
Journal:  Gigascience       Date:  2013-05-01       Impact factor: 6.524

5.  Whole genome and transcriptome sequencing of matched primary and peritoneal metastatic gastric carcinoma.

Authors:  J Zhang; J Y Huang; Y N Chen; F Yuan; H Zhang; F H Yan; M J Wang; G Wang; M Su; G Lu; Y Huang; H Dai; J Ji; J Zhang; J N Zhang; Y N Jiang; S J Chen; Z G Zhu; Y Y Yu
Journal:  Sci Rep       Date:  2015-09-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.